The Ministry of Industry and Information Technology announced that a total of 38 innovative drugs received market approval in the first half of the year. Among these approvals, 31 were domestic innovative drugs, accounting for more than 80% of the total.
Furthermore, outbound technology licensing for innovative drugs reached a new high during the same period, with the total transaction value surpassing 100 billion US dollars.